Skip to content
healthcare.dev

Ritonavir

NDC 65162-061, Ritonavir, tablet, from Amneal Pharmaceuticals LLC.

Product NDC
65162-061
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208890
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-061 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RITONAVIR100 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Protease Inhibitor [EPC]; UDP Glucuronosyltransferases Inducers [MoA]

Package NDCNDC-11Package
65162-061-066516200610660 TABLET in 1 BOTTLE (65162-061-06)
65162-061-3265162006132360 TABLET in 1 BOTTLE (65162-061-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a32cb2e3-d4e5-4bbf-9d88-20b2b249e779

Use it

Look up 65162-061 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-061 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.